Table 1.
Increased IMP3 signatures were independently associated with age, high-risk factors, and the status of pelvic serous carcinoma
| Age (Mean ± SD) |
Low risk (n = 196) |
High risk (n = 60) #IMP3-S/Group |
PSC (n = 60) |
|||
|---|---|---|---|---|---|---|
| fimbria | ampulla | fimbria | ampulla | fimbria | ampulla | |
| 20–29 (25 ± 1.9) |
0.00 |
0.00 |
0.00 |
0.00 |
- |
- |
| 30–39 (34 ± 1.8) |
0.00 |
0.00 |
5 |
0.00 |
- |
- |
| 40–49 (46 ± 1.8) |
0.00 |
0.00 |
18 |
0.00 |
6 |
0.00 |
| 50–59 (55 ± 1.6) |
2 |
0.00 |
33 |
3 |
28 |
0.00 |
| 60–69 (63 ± 2.2) |
4 |
0.00 |
74 |
8 |
50 |
3 |
| 70–79 (76 ± 1.4) |
11 |
0.00 |
96 |
11 |
76 |
8 |
| >80 (84 ± 2.3) |
8 |
0.00 |
- |
- |
24 |
5 |
| Total | 25 | 0.00 | 226 | 22 | 184 | 16 |
PSC: pelvic serous carcinoma. #IMP3-S: the number of IMP3 signatures.
There was no high risk cases with age elder than 80 and no PSC cases younger than 40 in this study. There were only 5 PSC cases with age elder than 80.